Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v1-EN
Language French English
Date Updated 2017-10-10 2017-08-03
Drug Identification Number 00441627 00441627
Brand name APO-HYDRALAZINE APO-HYDRALAZINE
Common or Proper name HYDRALAZINE HYDRALAZINE
Company Name APOTEX INC APOTEX INC
Ingredients HYDRALAZINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE
Strength(s) 25MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code C02DB C02DB
ATC description ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON
Reason for shortage Other (Please describe in comments) Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-07-31 2017-07-31
Estimated end date 2017-08-04 Unknown
Actual end date 2017-10-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments – Regulatory DIN Transfer
Health Canada comments